>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • COHU +9.8%, (raises Q2 revenue guidance), FAST +7.8%, HCSG +3.9%, (also declared quarterly cash dividend of $0.18875/share, up from prior $0.1875/share ), AAL +3.5%, (raises Q2 unit rev and pre-tax margin guidance), AIR +1.6%, OZRK +1.5%, .
M&A news:
  • IDSY +3.4% (to acquire substantially all of the assets of electronics manufacturer/marketer Keytroller; proposes underwritten public offering)
  • LOGI +1.6% (to acquire console gaming brand ASTRO Gaming for $85 million in cash)
  • ABM +0.8% (to acquire GCA Services Group), .
Select oil/gas related names showing strength:
  • SND +5.3%, NFX +3.4%, CLR +2.5%, WLL +2.4%, SLCA +1.9%, HCLP+1.6%, CHK +1.5%, SM +1.4%, SN +1.1%, APA +1%, DVN +0.9%
Other news:
  • NTP +22.6% (confirms share purchase agreement to sell 6,504,355 shares of the Company held by the co's Chairman M.K. Koo and his wife at $17.00/share to the Kaisa Group)
  • TROV +16% (announces Novogene will purhcase NextCollect for validation in the Chinese market)
  • NAK +15.1% (EPA has begun process to withdraw Proposed Determination that would have restricted development of Pebble Project in southwest Alaska)
  • CARA +14.6% (announces summary results from its Phase 1 safety and pharmacokinetic trial of Oral CR845)
  • CRNT +9.5% (received in Q2 orders totaling more than $9 mln for its IP-20 Platform)
  • NRG +9.1% (to hold call tomorrow July 12 at 8:30am ET to provide the results of its business review and detailed plan to transform the company)
  • DRRX +6.3% (upgraded to Buy from Hold at Stifel)
  • BDSI +5.7% (BioDelivery Sciences and Purdue Pharma (Canada) announce that they have signed an exclusive agreement for the licensing, distribution, marketing and sale of BELBUCA)
  • PYPL +3.2% (now available on Apple (AAPL) App Store, Apple Music, iTunes & more)
  • TAHO +2.7% (extending today's rebound -- down approx 40% month-to-date)
  • CLNT +1.8% (launched global bike sharing app service that joins local sharing bike operators in Hong Kong)
  • VBIV +1.6% (announces plans for Ph 3 clinical program for Sci-B-Vac following positive discussions with the FDA, EMA and Health Canada)
Analyst comments:
  • NVDA +0% (upgraded to Buy from Hold at SunTrust)